FMR LLC 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-10 09:48 am Purchase | 2024-06-07 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 6,303,217 11.392% | 3,493,208 (+124.31%) | Filing |
| 2024-02-09 09:03 am Sale | 2024-02-08 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 2,810,009 6.656% | -307,385 (-9.86%) | Filing |
| 2023-02-09 10:59 am Purchase | 2023-02-09 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 3,117,394 7.457% | 632,560 (+25.46%) | Filing |
| 2022-02-09 09:20 am Sale | 2022-02-08 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 2,484,834 6.699% | -95,800 (-3.71%) | Filing |
| 2021-02-08 10:21 am Purchase | 2021-02-05 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 2,580,634 7.041% | 2,580,634 (New Position) | Filing |